Atea Announces Presentation of Bemnifosbuvir Data Demonstrating Reduced…
<!-- Name:DistributionId Value:8805942 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Browsing Tag
Bemnifosbuvir
New Data Showcasing Favorable Profile of Bemnifosbuvir for Treatment of COVID-19 and…
<!-- Name:DistributionId Value:8787356 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
New Data Showcasing Favorable Profile of Bemnifosbuvir for Treatment of COVID-19 and…
<!-- Name:DistributionId Value:8783548 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Atea Pharmaceuticals to Present Data on Bemnifosbuvir Drug Interaction Profile at…
<!-- Name:DistributionId Value:8750098 -->
<!-- Name:EnableQuoteCarouselOnPnr Value:False -->…
Atea Pharmaceuticals Reports Nonclinical Bemnifosbuvir (AT-527) Toxicology Data at…
BOSTON, March 28, 2022 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (“Atea”), a clinical-stage biopharmaceutical company, today presented two posters highlighting…